stars 1 stars 2 stars 3

Scioto Biosciences is a Clinical stage biotech company dedicated to innovative research and discovery in the field of microbiome therapeutics. Our team has developed a proprietary Activated Bacterial Therapeutics (ABT) platform for delivering best-in-class, live therapeutic bacteria to the gut. Our solution is focused on the activation of beneficial bacteria that have the potential to advance healing for various diseases associated with the GI tract, Oncology and CNS indications.

Scioto Biosciences, Inc Questions

The Scioto Biosciences, Inc annual revenue was $10 million in 2026.

Joseph Trebley is the CEO of Scioto Biosciences, Inc.

3 people are employed at Scioto Biosciences, Inc.

Scioto Biosciences, Inc is based in Indianapolis, Indiana.

The NAICS codes for Scioto Biosciences, Inc are [541714, 5417, 541, 54, 54171].

The SIC codes for Scioto Biosciences, Inc are [873, 87].

Top Scioto Biosciences, Inc Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users